Healthcare > Medical Devices & Equipment
•437 stocks
•
Total Market Cap: Loading...
Market Cap Distribution
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (437)
%
| Company | Market Cap | Price |
|---|---|---|
|
Amedisys provides home health, hospice, and high-acuity in-home care services, aligning with hospital/services provider themes.
|
$3.31B |
$100.99
+0.01%
|
|
Nobel Biocare premium implants, Alpha-Bio, and Implant Direct are prosthetics/implants products.
|
$3.23B |
$19.06
-4.94%
|
|
ICU Medical’s core products are medical devices and equipment (infusion pumps, hazardous-drug handling systems).
|
$3.01B |
$119.67
-0.24%
|
|
TRS-RenTelco provides electronic test/diagnostic equipment rental and related services.
|
$2.81B |
$114.00
-1.77%
|
|
Directly manufactures and sells neuromodulation devices including VNS Therapy for epilepsy and proximal HGNS for OSA.
|
$2.76B |
$50.69
-2.14%
|
|
Nexplanon implant and Jada System are prosthetics/implants and medical devices.
|
$2.75B |
$10.65
+0.80%
|
|
Veracyte provides laboratory testing services and advisory/clinical-evidence support for test development and deployment.
|
$2.73B |
$34.80
-0.66%
|
|
Laboratory Testing & Advisory Services: includes bench-scale refining/testing activities tied to processing trials (via partners).
|
$2.68B |
$7.41
+2.21%
|
|
Provides diagnostic testing and advisory services within its occupational health centers and onsite clinics.
|
$2.67B |
$20.82
+0.77%
|
|
Scientific segment focuses on specialty temperature-controlled equipment used in healthcare and labs, aligning with diagnostic equipment.
|
$2.62B |
$217.17
-1.72%
|
|
Dentsply Sirona manufactures dental imaging devices, CAD/CAM systems, and other dental practice equipment.
|
$2.49B |
$12.50
+2.21%
|
|
Galleri is a liquid biopsy-based cfDNA methylation test that detects multiple cancers, fitting the Liquid Biopsy investable theme.
|
$2.38B |
$66.13
-7.38%
|
|
Haemonetics' TEG 6s hemostasis analyzer is a core hospital diagnostic device.
|
$2.35B |
$48.85
-2.81%
|
|
Medi-spa equipment and devices used for premium wellness treatments on cruise ships constitute medical/surgical equipment usage.
|
$2.27B |
$22.12
-0.85%
|
|
Ophthalmology devices in the Bausch Health portfolio through Bausch + Lomb.
|
$2.24B |
$6.05
-4.87%
|
|
Inspire Medical Systems' flagship product is a neuromodulation device (Inspire V) delivering hypoglossal nerve stimulation for OSA.
|
$2.22B |
$75.17
-6.27%
|
|
PROCEPT's Aquablation robotic systems are surgical devices used in urology procedures (BPH) and are sold as capital surgical equipment.
|
$2.17B |
$39.15
+1.77%
|
|
Laboratory testing services and advisory capacity related to MRD diagnostics and sequencing.
|
$2.03B |
$13.36
-3.68%
|
|
Ophthalmology Devices captures devices used in eye care and diagnostics, relevant to National Vision's eye-care operations.
|
$2.02B |
$25.56
-6.37%
|
|
Directly provides hospital-based inpatient and outpatient medical care services (acute care, urgent care, physician practice networks).
|
$2.01B |
$14.05
-2.57%
|
|
DEXTENZA and intravitreal/ intracameral formulations are ophthalmology devices and related delivery systems.
|
$1.94B |
$12.48
+1.88%
|
|
Spinal implants and fixation devices place Alphatec squarely in the Orthopedic Devices category.
|
$1.92B |
$13.14
-4.58%
|
|
Directly produces vascular surgical devices (grafts, patches, shunts, catheters) categorized as Surgical Equipment.
|
$1.90B |
$86.56
+2.82%
|
|
Liquid biopsy and MRD-focused NGS diagnostics indicate a liquid biopsy product line.
|
$1.87B |
$31.19
-6.39%
|
|
AtriCure sells surgical equipment such as the EnCompass Clamp and related devices used in cardiac surgery and ablation procedures.
|
$1.79B |
$36.18
-0.47%
|
|
QuidelOrtho directly manufactures and sells diagnostic instruments used in laboratories for disease detection.
|
$1.78B |
$26.37
-6.56%
|
|
Directly manufactures orthopedic implants and devices (hip/knee systems) under Enovis Recon, aligning with Orthopedic Devices.
|
$1.74B |
$30.20
-0.85%
|
|
Laboratory testing & advisory services related to testing facilities and regulatory compliance.
|
$1.72B |
$45.83
-5.10%
|
|
Company's core revenue derives from cardiology devices (e.g., On-X heart valve, arch repair devices).
|
$1.72B |
$40.20
-1.18%
|
|
VRDN-003 strategy includes subcutaneous administration via auto-injector, i.e., Auto-Injector Devices.
|
$1.71B |
$20.99
-3.94%
|
|
Provides patient monitoring capabilities (remote vital-sign tracking) as part of in-home care services.
|
$1.69B |
$8.65
-1.82%
|
|
Directly provides Laboratory Testing & Advisory Services, including testing, regulatory advisory, and related analytical capabilities.
|
$1.68B |
$13.75
-1.08%
|
|
MACI is an implant used for knee cartilage repair, aligning with the Orthopedic Devices category as a primary product type for the company.
|
$1.60B |
$31.85
-3.51%
|
|
SEM’s core offerings are hospital-based post-acute care services (Inpatient Rehabilitation Hospitals, Critical Illness Recovery Hospitals, and Outpatient Rehabilitation clinics), i.e., hospital services.
|
$1.59B |
$12.35
-2.45%
|
|
TXG manufactures and sells laboratory instrumentation (Chromium, Spatial platforms) used for genomic analysis, i.e., diagnostic equipment.
|
$1.55B |
$12.39
+5.45%
|
|
UFPT directly designs and manufactures medical device consumables, including sterile, single-use components and related sterile packaging elements.
|
$1.50B |
$195.22
+0.25%
|
|
Optune/TTFields devices are medical hardware used in cancer treatment, fitting under surgical equipment as a medical device category.
|
$1.50B |
$13.49
-5.99%
|
|
XT Series automated dispensing systems are hardware-based medical device components.
|
$1.43B |
$30.62
+0.39%
|
|
Azenta offers laboratory testing and advisory services through its GENEWIZ Genomics Services platform, including sequencing and related data generation.
|
$1.41B |
$30.73
-3.30%
|
|
Laboratory Testing & Advisory Services aligns with Evotec's preclinical/testing and regulatory/compliance support offerings.
|
$1.38B |
$7.28
|
|
Directly manufactures and sells surgical equipment including the SSi Mantra robotic system and instruments.
|
$1.35B |
$6.95
-7.09%
|
|
STAAR primarily designs, manufactures, and sells ophthalmology devices (implantable lenses) used in refractive surgery, categorized under Ophthalmology Devices.
|
$1.32B |
$26.75
-0.26%
|
|
CNMD directly manufactures surgical equipment used in operating rooms, including AirSeal, Buffalo Filter, and related disposable instruments.
|
$1.32B |
$42.68
-6.42%
|
|
Neogen directly manufactures diagnostic equipment and platforms (e.g., MDS pathogen detection system and Petrifilm automated reader) used for food and animal safety testing.
|
$1.31B |
$6.04
-12.21%
|
|
BHE designs and manufactures medical device components/subsystems for regulated markets.
|
$1.30B |
$35.97
-4.36%
|
|
Motiva Implants are prosthetic breast implants manufactured and sold by ESTA for aesthetics and reconstruction.
|
$1.22B |
$41.43
-2.03%
|
|
Cardiology ablation catheters and surgical AF devices (e.g., 360 Catheter, AF Clamp) are directly categorized as Cardiology Devices.
|
$1.22B |
$18.12
+2.66%
|
|
OPKO's BioReference Diagnostics segment provides Laboratory Testing & Advisory Services (clinical/diagnostic testing).
|
$1.20B |
$1.51
-3.21%
|
|
Consumables and services revenue is a core recurring stream for device users (Disposable consumables for RF platforms).
|
$1.18B |
$15.27
-4.59%
|
|
The business includes home-health devices used for patient monitoring and at-home care, aligning with the Home Health Monitoring Devices category.
|
$1.17B |
$8.70
-3.65%
|
|
PanTracer liquid biopsy and RaDaR MRD assays represent major liquid biopsy offerings expanding detection in solid tumors and MRD.
|
$1.17B |
$9.10
+1.56%
|
|
iovera is a medical device used in outpatient procedures; Pacira markets and sells this surgical device.
|
$1.17B |
$25.24
-2.28%
|
|
Offers laboratory testing and advisory analytical services to customers.
|
$1.15B |
$25.53
-7.97%
|
|
Core product category; wearable cardioverter defibrillators and related cardiology devices directly produced by Kestra.
|
$1.13B |
$22.00
-6.82%
|
|
CTS supplies Medical Device Components, aligning with its focus on high-value, niche medical device applications.
|
$1.10B |
$36.74
-4.32%
|
|
Integra's core surgical devices and instruments are used across neurosurgery, ENT, and reconstructive procedures.
|
$1.04B |
$13.34
-5.86%
|
|
Medical Device Components – production of components used in medical heating/temperature management devices.
|
$1.03B |
$33.48
-2.11%
|
|
Wound care devices including placental tissue allografts (EPIFIX, EPIEFFECT, HELIOGEN, EPIXPRESS) and related adjunct therapies constitute MiMedx's core product line.
|
$967.45M |
$6.55
-5.21%
|
|
The product includes an intravitreal implant device (drug-delivery implant) used to treat ocular conditions.
|
$956.48M |
$13.90
+4.91%
|
|
Montrose provides laboratory testing and advisory services, including PFAS testing and regulatory advisory.
|
$948.82M |
$27.54
-0.69%
|
|
Insulin pumps are medical devices used for automated insulin delivery, which is Tandem's core hardware offering (t:slim X2, Mobi).
|
$932.50M |
$14.00
-5.47%
|
|
Infusion sets and cartridges are consumables integral to Beta Bionics' insulin-pump system, representing a core recurring revenue stream.
|
$911.78M |
$21.03
-7.72%
|
|
The company derives recurring revenue from disposables used with its MRI-compatible devices.
|
$911.42M |
$71.68
-4.85%
|
|
Direct product category: safety syringes manufactured and sold by Embecta.
|
$834.00M |
$14.47
+1.47%
|
|
BST includes diagnostic/analytical kit products and related testing/advisory services for biologics manufacturing.
|
$812.36M |
$3.19
-3.92%
|
|
CareDx provides diagnostic testing services and related lab products/software for transplant diagnostics.
|
$801.24M |
$14.39
-2.64%
|
|
Datapoints and related data/analytical services align with Laboratory Testing & Advisory Services.
|
$791.35M |
$13.52
-12.04%
|
|
Dental equipment category covers Stratasys' dental 3D printing tools and dental lab applications used in dentistry.
|
$743.83M |
$10.42
-7.54%
|
|
Core neurosurgery hardware and associated surgical devices (navigation, drill, laser) used in procedures.
|
$730.80M |
$26.11
-10.61%
|
|
Medical device components are a core output in KE's Medical CMO expansion.
|
$729.22M |
$29.91
+1.08%
|
|
Directly used in Axogen's nerve repair surgical procedures (nerve grafting, connectors, etc).
|
$728.25M |
$15.99
-2.26%
|
|
DefenCath is a disposable medical device consumable used with catheters to prevent catheter-related bloodstream infections (CRBSI).
|
$727.76M |
$10.73
-2.28%
|
|
NeXT Personal is a tumor-informed ultra-sensitive liquid biopsy MRD test, i.e., a liquid biopsy product/service.
|
$717.20M |
$8.12
-6.67%
|
|
Laboratory testing and advisory services directly provided by the company, core to its business model.
|
$709.77M |
$7.72
+0.78%
|
|
Direct Laboratory Testing & Advisory Services across Precision Diagnostics, Anatomic Pathology, and BioPharma Services.
|
$685.29M |
$22.51
-1.01%
|
|
PIL-BOX space biotech work implies related Laboratory Testing & Advisory Services and analytical capabilities.
|
$673.71M |
$8.74
-8.19%
|
|
Castle Biosciences primarily delivers molecular diagnostic tests and laboratory testing services (DecisionDx-Melanoma, DecisionDx-SCC, TissueCypher, etc.), i.e., laboratory testing & advisory services.
|
$666.37M |
$23.08
-3.11%
|
|
SI-BONE directly manufactures surgical implants and related devices used in sacropelvic and SI joint procedures.
|
$629.84M |
$14.78
-5.80%
|
|
Plans to launch via prefilled syringes reflect a ready-to-use delivery format for ocular injections.
|
$626.30M |
$11.87
-11.42%
|
|
Prysm iO and related wellness devices fall under medical devices & biometric sensing.
|
$596.91M |
$12.01
-0.33%
|
|
Core ultrasound hardware (Ultrasound-on-Chip) and imaging software constitute Butterfly's primary medical-imaging product line.
|
$563.82M |
$2.28
-10.59%
|
|
Company directly manufactures Surgical Equipment used in operating rooms, including spinal hardware and navigation-assisted devices.
|
$556.37M |
$14.20
+1.50%
|
|
Core diagnostic ultrasound equipment is a direct product offering.
|
$536.62M |
$2.17
+15.43%
|
|
Bioventus' Surgical Solutions include ultrasonic bone resection systems (neXus, BoneScalpel) and PNS trial leads, representing direct surgical hardware and devices.
|
$534.76M |
$6.51
-1.66%
|
|
Directly manufactures dental implants and related prosthetic dental implant devices (premium implant platforms).
|
$527.72M |
$18.91
+0.08%
|
|
AirSculpt operates in the medical aesthetics space delivering proprietary contouring procedures, aligning with Medical Devices & Biometrics.
|
$511.97M |
$8.71
+0.11%
|
|
Organogenesis' core wound-care offerings include wound care devices and biomaterial barriers (e.g., PuraPly family) used in wound management.
|
$502.34M |
$3.96
-2.46%
|
|
Design and manufacture of customized components and subsystems used in medical devices, including X-ray tubes and detectors.
|
$500.49M |
$12.06
+1.09%
|
|
LAB provides SomaScan services to customers (translational/clinical research), i.e., laboratory testing and advisory services.
|
$497.57M |
$1.31
-5.07%
|
|
Avanos markets and sells surgical devices and related equipment (e.g., pain pumps and delivery systems), aligning with the Surgical Equipment category.
|
$494.81M |
$10.70
-4.63%
|
|
Medical Device Components: The CR3 medical headset and related display/optical modules position Kopin as a supplier of medical device components.
|
$486.77M |
$2.99
-8.28%
|
|
Core Lab directly provides Laboratory Testing & Advisory Services for reservoir description and production optimization.
|
$484.30M |
$10.33
-4.35%
|
|
Operates Laboratory Testing & Advisory Services as part of its hospital/clinic network.
|
$484.16M |
$6.55
-0.30%
|
|
CTS-related advisory/testing services align with outsourced testing/advisory offerings.
|
$470.80M |
$18.24
-2.25%
|
|
Cytek's instrument platforms are diagnostic equipment used for cell analysis in research and potential clinical workflows.
|
$462.00M |
$3.67
+1.52%
|
|
Core focus on pediatric orthopedic devices, including implants and braces, which directly aligns with OrthoPediatrics' product portfolio.
|
$452.78M |
$17.93
-1.94%
|
|
Auryon, AlphaVac, AngioVac, and NanoKnife are direct medical devices used in cardiovascular/interventional procedures, aligning with Cardiology Devices.
|
$446.97M |
$11.00
-6.38%
|
|
Ceribell's point-of-care EEG device functions as a diagnostic equipment for rapid neurological assessment.
|
$431.91M |
$11.95
-6.64%
|
|
PacBio designs and sells sequencing instruments and related hardware used in genetic analysis, i.e., diagnostic equipment.
|
$426.12M |
$1.42
-8.97%
|
|
Core product category for bunion correction devices and related implants.
|
$418.95M |
$6.66
-0.15%
|
Showing page 2 of 5 (437 total stocks)
Loading industry metrics...
Loading comparison data...
